US2017027894A1PendingUtilityA1

Systems and methods for bio-matching gels, creams and lotions

Assignee: GOOD CLEAN LOVE INCPriority: Dec 19, 2014Filed: Oct 14, 2016Published: Feb 2, 2017
Est. expiryDec 19, 2034(~8.4 yrs left)· nominal 20-yr term from priority
Inventors:Wendy Strgar
A61K 31/191G01N 33/50A61K 9/0034A61K 9/00A61K 9/06A61K 47/36
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of bio-matching a topical gel, cream or lotion may comprise selecting a vagina of a living body, identifying a secretion of the selected vagina, identifying a composition of the identified secretion, and formulating the topical gel to match the identified composition of the identified secretion.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of bio-matching a topical gel, the method comprising: selecting a vagina of a living body; identifying a secretion of the selected vagina; identifying a composition of the identified secretion; and formulating the topical gel to match the identified composition of the identified secretion. 
     
     
         2 . The method of  claim 1 , wherein the body is a human body. 
     
     
         3 . The method of  claim 1 , wherein identifying the secretion involves identifying a secretion present in a generally healthy vagina. 
     
     
         4 . The method of  claim 3 , wherein identifying the composition of the identified healthy secretion involves identifying lactic acid. 
     
     
         5 . The method of  claim 4 , wherein identifying lactic acid involves identifying lactic acid having a racemic index in a range of about 50% L/50% D. 
     
     
         6 . The method of  claim 5 , wherein formulating the topical gel involves selecting lactic acid having an approximately racemic mixture with between 30% to 70% L and between 70% to 30% D. 
     
     
         7 . The method of  claim 6 , wherein formulating the topical gel involves formulating the topical gel to include about 1% of the selected lactic acid. 
     
     
         8 . The method of  claim 3 , wherein formulating the topical gel involves bio-balancing the topical gel by avoiding inclusion of one or more ingredients that are toxic to microbiota of the generally healthy vagina. 
     
     
         9 . The method of  claim 3 , wherein formulating the topical gel involves using a preselected type and quantity of lactic acid, and causing the topical gel to have a preselected pH and salt balance that matches those of a healthy vagina. 
     
     
         10 . A topical gel for human use, the gel comprising: a formulation matched to a composition of a particular part of a human body, the formulation including lactic acid. 
     
     
         11 . The gel of  claim 10 , wherein the particular part of the human body is a vagina. 
     
     
         12 . The gel of  claim 11 , wherein the composition is a generally healthy composition associated with the vagina. 
     
     
         13 . The gel of  claim 12 , wherein the generally healthy composition includes lactic acid having a racemic index of about 50% L/50% D. 
     
     
         14 . The gel of  claim 13 , wherein the formulation comprises approximately 1% lactic acid having a racemic index in a range of about 30% L/70% D to about 70% L/30% D. 
     
     
         15 . The gel of  claim 14 , wherein the racemic index of the 1% lactic acid is approximately 50% L/50% D. 
     
     
         16 . A vaginal lubricant, comprising: a formulation including lactic acid having a racemic index that is bio-matched but not bio-identical to a racemic index of natural lubricants in a healthy vagina. 
     
     
         17 . The lubricant of  claim 16 , wherein vagina bacteria of the healthy vagina is dominated by  Lactobacillus crispatus  which produce lactic acid that is included in the natural lubricants, the lactic acid of the natural lubricants having a racemic index of approximately 50% L/50% D. 
     
     
         18 . The lubricant of  claim 17 , wherein the lactic acid of the formulation has a racemic index in a range of 80% L/20% D to 20% L/80% D, thereby resulting in the formulation being bio-matched to the natural lubricants of the healthy vagina.

Join the waitlist — get patent alerts

Track US2017027894A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.